ClearPoint Neuro, Inc. MRIC Income Statement

Clearpoint neuro, inc. (MRIC)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Revenues:
Service revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Product revenues
-	-	-	-	-	-	-	-	-	-	-	-	6,156	5,600	5,469	5,097	4,805	4,416	3,882	3,261	3,642	3,378	3,563	3,824	3,167	2,914	2,146	1,615	1,409	1,170	1,282	1,468	1,250	1,154	0	0	0
Development service revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	103	119	168	228	283	431	0	0	-	0	-	-	-	-	-	-
Service and other revenues
-	-	-	-	-	-	-	-	-	-	-	-	205	149	145	143	135	140	133	144	144	121	113	0	0	-	0	-	-	-	-	-	-	-	-	-	-
Related party license revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	650	2,046	2,696	3,346	3,346	2,600	2,600	2,600	2,600	0	0	0
Total revenues
11,860	11,216	10,282	9,162	8,202	7,353	6,756	6,666	6,995	7,379	7,335	7,234	6,362	5,749	5,625	5,256	4,977	4,594	4,042	3,429	3,792	3,604	3,821	4,115	3,488	3,930	4,616	4,821	5,342	5,058	4,359	4,382	4,021	3,818	0	0	0
Cost of revenues
3,863	3,832	3,588	3,158	2,730	2,433	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of revenues
-	-	-	-	-	-	-	-	-	-	-	-	2,698	2,642	2,612	2,424	2,298	1,987	2,024	1,779	1,962	1,927	1,777	1,826	1,545	1,421	1,051	819	680	555	626	801	675	656	0	0	0
Research and development costs
3,167	2,922	2,525	2,380	2,348	2,310	2,410	2,383	2,802	2,813	2,761	2,862	2,528	2,628	2,621	2,410	2,087	1,957	2,142	2,535	3,007	3,297	3,273	3,125	2,969	2,922	2,973	2,822	2,566	2,484	2,867	3,203	3,776	4,251	0	0	0
Sales and marketing expenses
5,013	4,755	4,125	3,827	3,610	3,532	3,664	3,798	3,852	3,956	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Reversal of research and development obligation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-
General and administrative expenses
4,645	4,299	4,197	4,245	4,305	4,325	4,379	4,167	4,015	4,046	1,228	2,247	3,200	4,190	7,510	7,757	8,056	8,370	8,856	8,785	8,527	8,039	7,819	7,454	7,228	7,061	6,479	6,223	6,323	6,029	5,707	5,633	4,936	4,831	0	0	0
Restructuring charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,252	1,252	1,252	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of intellectual property
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,338	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Total costs and operating expenses
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8,187	8,319	8,755	9,387	9,739	0	0	0
Operating loss
-4,829	-4,593	-4,154	-4,450	-4,792	-5,247	-6,101	-6,222	-6,409	-6,335	-6,293	-6,675	-6,908	-7,488	-7,118	-7,335	-7,963	-8,974	-10,233	-10,924	-10,457	-5,320	-4,710	-3,953	-3,915	-7,474	-5,887	-5,043	-3,344	-3,129	-3,959	-4,373	-5,365	-5,921	0	0	0
Other income (expense):
Gain on change in fair value of derivative liabilities
-	-	-	-	-	64	40	128	152	24	365	580	812	1,065	1,306	2,933	2,482	1,539	1,952	-778	283	1,549	936	466	546	1,686	-339	0	0	-	0	-	-	-	-	-	-
Loss on debt restructuring
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on forgiveness of amounts in accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Loss on note payable modification
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,356	0	0	0	-	-	-	-	-	-	-	-
Other income (expense), net
-29	9	6	8	6	0	11	12	11	16	13	5	145	216	196	247	223	230	251	244	154	175	-182	-181	-214	56	408	343	0	-	0	0	-	104	0	0	0
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16	16	16	16	11	13	16	20	24	24	26	19	14	10	3	4	3	0	0	0
Interest expense, net
1,514	955	964	997	987	980	978	942	907	872	852	880	919	1,051	1,162	1,239	1,299	1,262	1,230	1,203	1,175	1,018	860	699	545	499	450	408	374	2,594	3,159	3,779	4,282	2,498	0	0	0
Net loss
-6,373	-5,539	-5,112	-5,417	-5,743	-6,163	-7,027	-7,024	-7,152	-7,167	-6,766	-7,904	-7,681	-8,069	-7,587	-5,269	-6,547	-8,449	-9,165	-12,567	-11,100	-4,524	-4,325	-3,873	-3,632	-7,086	-4,412	-3,979	-3,227	-5,877	-8,691	-8,065	-9,535	-8,311	0	0	0
Net loss per share attributable to common stockholders:
Basic and diluted (in dollars per share)
-0.13	-0.10	-0.08	-0.13	-0.11	-0.11	-0.13	-0.17	-0.15	-0.01	-0.14	-0.32	-0.46	-0.22	-0.92	-0.90	-0.89	-2.66	-0.13	-1.64	-0.05	-	0.00	-	-	-	-0.05	-	-	0.06	-0.06	-0.01	-0.14	-0.12	-0.13	-0.13	-0.14
Weighted average shares outstanding:
Basic and diluted (in shares)
15,438	15,220	14,053	12,302	11,044	11,004	11,006	10,959	10,741	10,676	10,339	6,315	3,622	3,977	2,779	1,971	2,291	-71,047	1,872	1,871	74,842	-	58,957	-	-	-	58,254	-	-	48,181	47,531	40,596	25,187	16,084	16,041	15,859	15,859
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.03	0.04	-	-	-0.02	-0.02	-	-	-	-	-	-	-	-
Diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.03	0.04	-	-	-0.02	-0.02	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	58,919	58,716	-	-	57,384	54,860	-	-	-	-	-	-	-	-
Diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	58,919	61,248	-	-	57,384	54,860	-	-	-	-	-	-	-	-
Product Revenue
Total revenues
9,415	9,476	8,946	8,091	7,310	6,685	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service and Other Revenues
Total revenues
2,444	1,740	1,336	1,070	892	668	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-